Announcements Trials
Browse Landscape

Phase

Phase NA 6Phase 4 2Phase 3 1

Status

Unknown 1Recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

CNS 1

Conditions

Breast Neoplasms 277Neoplasms 202Prostatic Neoplasms 118Polycystic Ovary Syndrome 114Colorectal Neoplasms 104Carcinoma, Hepatocellular 103Carcinoma, Non-Small-Cell Lung 88Lung Neoplasms 70Stomach Neoplasms 62Precursor Cell Lymphoblastic Leukemia-Lymphoma 60Pain 59Neoplasm Metastasis 54Multiple Myeloma 52Pancreatic Neoplasms 46Keratosis, Actinic 46Pain, Postoperative 43Head and Neck Neoplasms 43Leukemia, Myeloid, Acute 40Leiomyoma 39Recurrence 38Liver Neoplasms 38Colonic Neoplasms 37Uterine Cervical Neoplasms 35Lymphoma 35Brain Neoplasms 34Infertility 33Papillomavirus Infections 32Ovarian Neoplasms 31Lymphoma, Follicular 31Lymphoma, Non-Hodgkin 30

Interventions

Fluorescein 1Bupivacaine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 4 × Interventional × Cerebrovascular Disorders × Clear all
NCT07049094 2025-07-03

The Analgesic Effect of Scalp Nerve Block Using Bupivacaine Liposomes for Postoperative Pain Relief After Craniotomy

Zhejiang University

Phase 4 Recruiting
218 enrolled

Cerebrovascular Disorders

NCT02478346 2017-02-14

Fluoescein

AdventHealth

Phase 4 Unknown
200 enrolled
CNS

Brain Neoplasms, Cerebrovascular Disorders

Data powered by HemOnc (CC BY 4.0) Colophon âš¡